Skip to main content

Table 3 Oct-4 expression – cycle characteristics

From: Markers of stem cells in human ovarian granulosa cells: is there a clinical significance in ART?

  Οct-4 expression p-value*
Yes median (IQR) No median (IQR)
Age (ys) 36.00 (35.00, 38.00) 36.00 (30.00, 37.00) 0.520
BMI 23.20 (19.80, 24.60) 22.80 (20.10, 26.30) 0.778
Serum FSH (IU/L) 6.30 (5.80, 7.50) 5.90 (4.30, 8.10) 0.545
SerumLH (IU/L) 4.50 (3.40, 4.60) 5.70 (3.40, 9.70) 0.165
SerumPRL (ng/ml) 11.40 (9.70, 15.30) 10.40 (5.50, 25.10) 0.790
Total gonadotropin dose 2,675.00 (1800.0, 3200.0) 3,112.50 (2325.00, 3675.00) 0.364
Duration of stimulation (ds) 10.00 (9.00, 11.00) 10.00 (9.00, 11.00) 1.000
Serum estradiol on the 5th day of rFSH administration (pg/ml) 500.00 (350.00, 758.00) 455.00 (180.00, 890.00) 0.805
Serum estradiol on the day of hCG administration (pg/ml) 1,800.00 (1,200.00, 2,025.00) 2,283.50 (1,828.00, 2,617.00) 0.149
No of follicles aspirated 8.00 (6.00, 10.00) 8.50 (6.00, 10.00) 0.972
No of oocyte retrieved 8.00 (6.00, 9.00) 8.00 (6.00, 10.00) 0.887
Mature oocytes ratio (%) 75.00 (67.00, 80.0) 68.5 (67.0, 78.0) 0.415
  1. *Statistical Test.
  2. Presence or absence of Oct-4 mRNA expression in correlation with the patients’ cycle characteristics.